HomeDSGN • NASDAQ
add
Design Therapeutics Inc
Previous close
$5.79
Day range
$5.32 - $5.93
Year range
$1.96 - $6.91
Market cap
330.10M USD
Avg Volume
150.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.46M | -35.86% |
Net income | -11.79M | 40.85% |
Net profit margin | — | — |
Earnings per share | -0.21 | 41.67% |
EBITDA | -14.89M | 33.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 261.02M | -13.88% |
Total assets | 269.58M | -13.49% |
Total liabilities | 8.34M | -43.78% |
Total equity | 261.24M | — |
Shares outstanding | 56.62M | — |
Price to book | 1.26 | — |
Return on assets | -13.72% | — |
Return on capital | -14.02% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -11.79M | 40.85% |
Cash from operations | -11.26M | 18.43% |
Cash from investing | 27.33M | 128.12% |
Cash from financing | 229.00K | 9.05% |
Net change in cash | 16.30M | 1,111.29% |
Free cash flow | -7.46M | -11.30% |
About
Founded
2017
Headquarters
Website
Employees
57
